Loading...
Loading...
Morgan Stanley raised its rating on Walgreen
WAG from Overweight to Equalweight and removes its previous price target of $31.
Morgan Stanley noted, "The Express Scripts dispute is over, but focus now turns to growth prospects for Alliance Boots and related Europe risk. We still see an unsettled US EPS backdrop (couponing to win back Express customers, weak front-end and new Express-Medco contract margins)."
Walgreen closed at $35.52 on Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in